Stockholm3 Test May Aid Risk Prediction in Prostate Cancer Screening
TUESDAY, Aug. 31, 2021 -- The Stockholm3 test combined with magnetic resonance imaging (MRI)-targeted biopsy could detect clinically significant prostate cancer while decreasing overdetection, according to a study published online Aug. 12 in The...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news